<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8</volume><submitter>Lin Z</submitter><pubmed_abstract>Canine breast cancer (CBC) is the most common spontaneous tumor in intact female dogs, especially in developing countries. The effective anti-tumor agents or therapies for the clinical treatment of CBC are still in need. Auranofin (AF) is a gold complex that has been attested by FDA for treating human rheumatism, which has been found as a great anti-tumor agent in recent years. ICG-001 is a small molecule inhibitor of Wnt/β-catenin pathway. In the present study, we demonstrated that a combination of AF and ICG-001 could synergistically suppress the proliferation of CBC &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. Moreover, the synergistical effect was related with apoptosis caused by mitochondrial damage and ROS production. In conclusion, combination of AF and ICG-001 could synergistically suppress</pubmed_abstract><journal>Frontiers in veterinary science</journal><pagination>772687</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8714754</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Auranofin and ICG-001 Emerge Synergistic Anti-tumor Effect on Canine Breast Cancer by Inducing Apoptosis via Mitochondrial Pathway.</pubmed_title><pmcid>PMC8714754</pmcid><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Cheng N</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Auranofin and ICG-001 Emerge Synergistic Anti-tumor Effect on Canine Breast Cancer by Inducing Apoptosis via Mitochondrial Pathway.</name><description>Canine breast cancer (CBC) is the most common spontaneous tumor in intact female dogs, especially in developing countries. The effective anti-tumor agents or therapies for the clinical treatment of CBC are still in need. Auranofin (AF) is a gold complex that has been attested by FDA for treating human rheumatism, which has been found as a great anti-tumor agent in recent years. ICG-001 is a small molecule inhibitor of Wnt/β-catenin pathway. In the present study, we demonstrated that a combination of AF and ICG-001 could synergistically suppress the proliferation of CBC &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. Moreover, the synergistical effect was related with apoptosis caused by mitochondrial damage and ROS production. In conclusion, combination of AF and ICG-001 could synergistically suppress</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-04-08T09:00:06.19Z</modification><creation>2022-02-11T14:50:18.289Z</creation></dates><accession>S-EPMC8714754</accession><cross_references><pubmed>34977210</pubmed><doi>10.3389/fvets.2021.772687</doi></cross_references></HashMap>